期刊文献+

促性腺激素及IL-6对卵巢癌细胞株核因子-κB表达的影响 被引量:1

Effects of gonadotropins and IL-6 on the expression of nuclear factor kappa B in epithelial ovarian cancer cells
下载PDF
导出
摘要 目的:探讨促性腺激素及IL-6对卵巢癌细胞株核转录因子.KB(NF-KB)表达的影响.方法:应用不同剂量的人重组促性腺激素及人重组白介素.6(hrlL-6)与卵巢癌细胞株OVCAR-3,Caov-3共培养,应用四甲基偶氮唑蓝(MTT)实验观测其对卵巢癌细胞生长的影响,同时应用RT-PCR和ELISA方法检测卵巢癌细胞NF-κB水平,以分析其信号传导途径.结果:促性腺激素对卵巢癌细胞株具有促增殖作用,分别增加35%~202%(P〈0.05);67.7%~192%(P〈0.01),并使细胞内NF-κB亚单位表达增加1.53倍~3.98倍(P〈0.05),与对照组相比差异具有显著性.在处理组卵巢癌细胞培养液中加入50mg/L抗IL-6中和性抗体,上述2种卵巢癌细胞株的生长均有所减慢,NF-κB表达下降.结论:提示促性腺激素对卵巢癌细胞株的促增殖过程可能由IL-6介导,促性腺激素、IL击及NF-κB共同影响卵巢癌细胞的生长. AIM: To investigate the relationship of nuclear factor kappa B (NF-KB) with gonadotropins and human recombinant interleukin-6 (hrIL-6) in epithelial ovarian cancer cells. METHODS: Two epithelial ovarian carcinoma cell lines (OVCAR-3, Caov-3 ) were co-cultured with follicle-stimulating hormone (FSH) or luteinizing hormone (LH) or IL-6. The degree of proliferation of the 2 cell lines was determined by MTT. The expression of mRNA and protein of NF-KB in all cells were determined by RT-PCR and ELISA, respectively. ELISA was also used for detecting IL-6 in culture supernatants. RESULTS: A dose-response effect of FSH (40 - 100 U/L) was seen on the proliferation of OVCAR-3 cells ( 35% - 202%, P 〈 0.05 vs control group) and of Caov-3 cells (67.7% - 192% , P〈0.01 vs control group) ; the levels of NF-κB mRNA and protein were increased (1.53 -3.98 folds)by FSH, LH and hrIL-6 for a period of 96 h (P 〈 0.05 vs control group). Most significantly, for both cell lines, 50 mg/L IL-6-neutralizing antibodies partially inhibited the hormone-stimulated cell proliferation and completely inhibited cell proliferation that had been enhanced by hrIL-6. The increase in the levels of NF-KB mRNA and protein in cells treated with FSH, LH, hrIL-6 was blocked by IL-6-neutralizing antibodies. CONCLUSION: Gonadotropins-stimulated cell proliferation is mediated by IL-6. Gonadotropins, IL-6 and NF-KB are possibly responsible for the prognosis of ovarian cancer together.
出处 《第四军医大学学报》 北大核心 2007年第1期9-11,共3页 Journal of the Fourth Military Medical University
基金 天津市卫生局基金资助项目(01KY48)
关键词 卵巢肿瘤 促性腺激素 白细胞介素-6 ovarian neoplasms gonadotropins interleukin-6
  • 相关文献

参考文献10

  • 1Laura RC,James NM,Kenneth AR.Human glioblastoma cells release interleukin 6 in vivo and in vitro BMC[J].Infect Dis,2002,2:5-11.
  • 2陈红,胡琢英,邓晓谷.雌激素孕激素及促性腺激素对卵巢癌细胞株H0-8910体外生长的调控[J].中山医科大学学报,2001,22(1):29-32. 被引量:9
  • 3Qing JI,Liu PI,Chen PK,et al.Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells[J].Int J Can,2004,112(5):803-814.
  • 4Arslan AA,Zeleniuch-cquotte A,Liudin E,et al.Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women[J].Can Epid Biomark Prev,2003,12,1531-1535.
  • 5Viqar S,Marambaud P,Shioi J,et al.Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cell[J].Can Res,2001,61(9):6768-6776.
  • 6Terranova PF,Rice VM.Cytokine involvement in ovarian processes[J].Am J Reprod Immunol,2001,37(1):50-63.
  • 7Darai E,Detchev R,Hogol D,et al.Serum and cyst fluid levels of interleukin (IL)-6,IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumors[J].Hum Reprod,2003,18(8):1681-1685.
  • 8Kovacs E.Investigation of interleukin-6 (IL-6),soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients[J].Biomed Pharmacother,2001,55(7):391-396.
  • 9高燕,卢奕,陆伯刚,邢冬红,余章秋,姚智.人IL-1、IL-6及TNFα基因在卵巢癌患者单个核细胞中的表达与相互关系[J].天津医药,1998,26(11):647-649. 被引量:2
  • 10Yamagucchi MT,Kojima M,Kanekawa,et al.Neuropeptides stimulate production of interleukin-1 beta,interleukin-6,and tumor necrosis factor-alpha in human dental pulp cell[J].Inflamm Res,2004,53(5):199-204.

二级参考文献9

共引文献9

同被引文献8

  • 1何凯,崔满华,王琨,江元.NF-κB抑制剂对于人卵巢癌裸鼠移植瘤及其血管生成的影响[J].中国妇幼保健,2006,21(23):3292-3294. 被引量:4
  • 2Christine H,Holschneicerm MD,Jonathan S,et al.Advances in the understanding and treatment of ovarian cancer[J].J BR Menopause Soc,2005,11(2):66.
  • 3Salvatore C,Camarda G,Maggi CA,et al.NF-kappaB activation contributes to anthracyclinc resistance pathway in human ovarian carcinoma cell line A2780[J].Int J Oncol,2005,27(3):799.
  • 4Qing JI,Liu PI,Chen PK,et al.Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells[J].Int J Cancer,2004,112(5):803.
  • 5Arslan AA,Zeleniuch-Jacquotte A,Lundin E,et al.Serum folliclestimulating hormone and risk of epithelial ovarian cancer in postmenopausal women[J].Cancer Epidemiol Biomarkers Prey,2003,12 (12):1531.
  • 6Syed V,Ulinski G,Mok SC,et al.Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and mahgnant human ovarian surface epithelial cell[J].Cancer Res,2OO1,61(18):6768.
  • 7Lauzurica P,MartinezMS,Marazuela M,et al.Pyrrolidine dithiecarbamate protects mice from lethal shock induced by LPS or TNF-alpha[J].Eur J Immunol,1999,29 (6):1890.
  • 8陈红,胡琢英,邓晓谷.雌激素孕激素及促性腺激素对卵巢癌细胞株H0-8910体外生长的调控[J].中山医科大学学报,2001,22(1):29-32. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部